UK In-vitro Toxicology Testing Market Size & Outlook
UK in-vitro toxicology testing market, 2018-2030 (US$M)
Related Markets
UK in-vitro toxicology testing market highlights
- The UK in-vitro toxicology testing market generated a revenue of USD 1,691.8 million in 2023 and is expected to reach USD 3,892.8 million by 2030.
- The UK market is expected to grow at a CAGR of 12.6% from 2024 to 2030.
- In terms of segment, pharmaceutical industry was the largest revenue generating end user in 2023.
- Diagnostics is the most lucrative end user segment registering the fastest growth during the forecast period.
In-vitro toxicology testing market data book summary
| Market revenue in 2023 | USD 1,691.8 million |
| Market revenue in 2030 | USD 3,892.8 million |
| Growth rate | 12.6% (CAGR from 2023 to 2030) |
| Largest segment | Pharmaceutical industry |
| Fastest growing segment | Diagnostics |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Pharmaceutical Industry, Cosmetics And Household Products, Academic Institutes and Research Laboratories, Diagnostics, Chemicals Industry, Food Industry |
| Key market players worldwide | Charles River Laboratories International Inc, SGS, Merck KGaA, Eurofins Scientific SE, Abbott Laboratories, Labcorp Holdings Inc, Evotec SE, Thermo Fisher Scientific Inc, Quest Diagnostics Inc, Agilent Technologies Inc, Catalent Inc, Danaher Corp, Bio-Rad Laboratories Inc |
Other key industry trends
- In terms of revenue, UK accounted for 5.5% of the global in-vitro toxicology testing market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany in-vitro toxicology testing market is projected to lead the regional market in terms of revenue in 2030.
- UK is the fastest growing regional market in Europe and is projected to reach USD 3,892.8 million by 2030.
Pharmaceutical industry was the largest segment with a revenue share of 43.53% in 2023. Horizon Databook has segmented the UK in-vitro toxicology testing market based on pharmaceutical industry, cosmetics and household products, academic institutes and research laboratories, diagnostics, chemicals industry, food industry covering the revenue growth of each sub-segment from 2018 to 2030.
The UK in-vitro toxicology testing market is growing owing to an increasing regulatory burden to reduce animal drug testing, rising demand for cost-effective & more efficient testing procedures, and supportive research initiatives. For instance, in September 2016, UK laboratory XCellR8 received a Horizon 2020 grant to validate new in vitro tests for acute dermal toxicity.
The UK market is also driven by an increase in contract manufacturing of drugs, high demand for novel approaches for establishing safety profiles of drug testing, and accessibility to 3D cellular toxicology models. Some of the key operating players in the country are Wickham Laboratories, SGS UK, Intertek, and Eurofins Discovery Services.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
In-vitro Toxicology Testing Market Scope
In-vitro Toxicology Testing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
UK in-vitro toxicology testing market size, by end user, 2018-2030 (US$M)
UK In-vitro Toxicology Testing Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
